Ilika aligns solid state production with lithium-ion supply chains

Ilika Plc

Ilika’s Goliath programme has moved into a phase where its manufacturing process has been proven at scale using standard lithium-ion equipment, a key step in reducing both complexity and cost.

The company has already demonstrated its process at the UK Battery Industrialisation Centre using equipment that is commonly found in lithium-ion battery production lines. This reuse of proven tools allows Ilika to scale up without the delays or capital costs usually associated with custom setups. It also positions the company to take advantage of existing global supply chains.

Material choices are equally pragmatic. Most of the bill of materials for Goliath cells mirrors that of high-nickel NMC lithium-ion batteries, with a major difference being the electrolyte. Ilika uses a ceramic oxide that is widely available off the shelf, avoiding the need for specialised or rare additives. This focus on commoditised inputs helps keep costs predictable and scalable. Its silicon-based anode materials are expected to reach similar levels of availability and pricing in the near term, further improving the long-term economics.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search